SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-015998
Filing Date
2022-06-06
Accepted
2022-06-06 17:12:38
Documents
18
Period of Report
2022-06-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40827
2 ex3-1.htm EX-3.1 2092
3 ex99-1.htm EX-99.1 1819
4 ex3-1_001.jpg GRAPHIC 230213
5 ex3-1_002.jpg GRAPHIC 630646
6 ex99-1_001.jpg GRAPHIC 742718
7 ex99-1_002.jpg GRAPHIC 247882
  Complete submission text file 0001493152-22-015998.txt   2768485

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adxs-20220603.xsd EX-101.SCH 2956
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adxs-20220603_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adxs-20220603_pre.xml EX-101.PRE 22357
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3625
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 22998880
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences